CO and Philadelphia, PA) - Anjan Chatterjee, MD, has
been awarded the Norman Geschwind Prize in Behavioral
Neurology today by the American Academy of Neurology
at their 54th annual meeting. Chatterjee is an associate
professor in the Department of Neurology of the University
of Pennsylvania School of Medicine.
Chatterjee receives the award on the basis
of his research directed at understanding the architecture
and neural basis for human cognition. The major emphasis
of Chatterjee's lab is on the study of the human experience
of attention, perception, and language. Chatterjee and
his associates study normal people using functional
neuroimaging and patients with selective deficits following
brain damage to investigate mechanisms underlying human
"How we are able to experience our physical
surroundings is a fascinating question that is rooted
in the fundamental mechanisms of what we call consciousness,"
said Francisco Gonzalez-Scarano, MD, chair of the Department
of Neurology. "This award is in recognition of Dr. Chatterjee's
approach to expanding the scientific basis of neurobiological
Founded in 1999, the Norman Geschwind
Prize is awarded to an individual for outstanding research
in the field of behavioral neurology. The award honors
the late Dr. Norman Geschwind, the Harvard Medical School
and Boston University School of Medicine researcher
who was pivotal in establishing the field of behavioral
neurology in the United States. The prize is endowed
by Geschwind's family, friends, colleagues, Parke-Davis
Company and the Society for Behavioral and Cognitive
Neurology. Chatterjee's lab is based at Penn's Center
for Cognitive Neuroscience, a multidisciplinary group
of researchers whose shared goal is to understand the
neural basis of human thought. The center, formed in
1999, encompasses a wide range of research topics from
vision and attention to semantic memory and executive
# # #
The University of Pennsylvania Health System is
distinguished not only by its historical significance
- first hospital (1751), first medical school (1765),
first university teaching hospital (1874), first fully
integrated academic health system (1993) - but by its
position as a major player on the world stage of medicine
in the 21st century. Committed to a three-part mission
of education, research, and clinical excellence, UPHS
excels in all three areas.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.